Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART
Condition(s):Human Immunodeficiency Virus InfectionLast Updated:March 4, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Human Immunodeficiency Virus InfectionLast Updated:March 4, 2020Completed
Condition(s):HIV Infections; Substance Use; Adherence, Medication; Adherence, TreatmentLast Updated:March 15, 2024Recruiting
Condition(s):HIV InfectionsLast Updated:September 1, 2023Active, not recruiting
Condition(s):HIV InfectionsLast Updated:January 5, 2024Active, not recruiting
Condition(s):HIV/AIDSLast Updated:May 19, 2022Withdrawn
Condition(s):Pre-Exposure Prophylaxis of HIV InfectionLast Updated:March 22, 2024Recruiting
Condition(s):HIV InfectionsLast Updated:March 13, 2024Completed
Condition(s):Human Immunodeficiency VirusLast Updated:March 27, 2019Completed
Condition(s):HIVLast Updated:July 6, 2017Completed
Condition(s):HIVLast Updated:October 12, 2015Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.